Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Grabar Law Office is investigating claims on behalf of shareholders of Molina Healthcare, Inc. (NYSE: MOH).
-
PHILADELPHIA, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): WHAT IS HAPPENING? Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The...
-
PHILADELPHIA, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation...
-
PHILADELPHIA, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation...
-
PHILADELPHIA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE: ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE: ITGR)....
-
PHILADELPHIA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE: ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE: ITGR)....
-
PHILADELPHIA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE: ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE: ITGR)....
-
PHILADELPHIA, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corp. (NYSE: ITGR): Grabar Law Office is investigating claims on behalf of shareholders of Integer Holdings Corp. (NYSE: ITGR)....
-
PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...
-
PHILADELPHIA, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (NASDAQ: CYTK): Grabar Law Office is investigating claims on behalf of shareholders of Cytokinetics, Inc. (NASDAQ: CYTK). The...